Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

New ways for financing vaccination in Indonesia

Jakarta   /   Mon, March 13, 2017   /  02:45 pm
New ways for financing vaccination in Indonesia Puskemas Ciracas' staff administers vaccines to a child in East Jakarta, Monday July 18, 2016. In east Jakarta where at least 197 children received fake immunization are being revaccinated (The Jakarta Post/Seto Wardhana)

During autumn last year, the World Health Organization (WHO) announced that a vaccine to prevent dengue fever was available for people across the world aged 9 to 16 years old.  This should have been exceptionally welcome news in Indonesia, where dengue has affected more than 120,000 people at a cost of roughly US$323 million annually, according to the Indonesian Technical Advisory Group on Immunization.  Accordingly, last September, Indonesia's Food and Drug Monitoring Agency approved the dengue vaccine, making it widely available in the private market. Unfortunately, Indonesia continues to see its national coverage rates below the global average. Its vaccine delivery system has been plagued by several major hurdles including a strained public health infrastructure, the lack of a centralized body to manage vaccine procurement and delivery, and mixed public acceptance ...

Disclaimer: The opinions expressed in this article are those of the author and do not reflect the official stance of The Jakarta Post.